Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

ADALIMUMAB-AACF

FDA · BLA · 2025-12-23

AgencyFDA
Submission typeBLA
Action date2025-12-23
BrandIDACIO
SponsorFRESENIUS KABI USA
RouteSUBCUTANEOUS

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:35:07.273Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:ADALIMUMAB-AACF:2025-12-23

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

ADALIMUMAB-AACF — approval | AEaH